Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023634 · ClinicalTrials.gov registry record · Phase 1
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
A Phase 1 study, sponsored by SWOG Cancer Research Network.
- Terminated
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT00023634: Clinical Trial Phase 1 study, sponsored by SWOG Cancer Research Network.
NCT00023634 is a Phase 1 study that was terminated before completion, run by SWOG Cancer Research Network. The registered enrollment target is 14 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00023634, a Phase 1 study, was terminated before completion, sponsored by SWOG Cancer Research Network.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
RATIONALE: Vaccines made from a peptide may make the body build an immune response to kill cancer cells. PURPOSE: This phase I trial is studying two different vaccines to treat patients who have gastric, prostate, or ovarian cancer.
Interventions
- BIOLOGICAL KLH
- BIOLOGICAL GMCSF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2001-06 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Why NCT00023634 stopped before completion
NCT00023634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which KLH is the first listed.
NCT00023634 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00023634 about?
NCT00023634 is a clinical study titled "S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer". RATIONALE: Vaccines made from a peptide may make the body build an immune response to kill cancer cells. PURPOSE: This phase I trial is studying two different vaccines to treat patients who have gastric, prostate, or ovarian cancer.
What is the current status of trial NCT00023634?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2001-06. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00023634?
The interventions under investigation include: KLH (BIOLOGICAL), GMCSF (BIOLOGICAL).
Who is sponsoring clinical trial NCT00023634?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00023634's enrollment target sits among peer trials
14 1844th of 2000 higher than 154 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia